Literature DB >> 32420922

COVID-19: the critical balance between appropriate governmental restrictions and expected economic, psychological and social consequences in Italy. Are we going in the right direction?

Paolo Diego L'Angiocola1, Manuel Monti2.   

Abstract

Since the declaration of COVID-19 pandemic infection by the World Health Organization, many governmental restrictions have been differently applied in the involved countries in order to contain the spread of the infection; Italy applied severe restrictive, public measures actually confining the entire population to an almost complete lockdown for several weeks; the restrictive quarantine can be considered controversial when excessively prolonged over time, due to many possible economic, psychologic and social consequences with a remarkable impact on the population. In this article we analyze possible collateral damages related to the prolonged quarantine.

Entities:  

Mesh:

Year:  2020        PMID: 32420922      PMCID: PMC7569627          DOI: 10.23750/abm.v91i2.9575

Source DB:  PubMed          Journal:  Acta Biomed        ISSN: 0392-4203


On March 2nd 2020 the Italian Government issued a new decree concerning COVID-19 emergency, which established additional restrictions to the population, actually imposing an almost complete lockdown of the nation (1). Data about the real and accurate prevalence of infection and disease related to COVID-19 are often unavailable, and always controversial. In a paper by Baud et al. according to WHO data on the cumulative overall number of deaths to March 1, 2020, case-fatality rates would be 5.6% (95% CI 5.4–5.8) for China and 1.5% (CI 1.2–1.7) outside of China (2). In a brilliant paper by Onder G et al. (3), case-fatality rate in Italy is estimated 7.2% by March 17th 2020, and the authors’ interpretation is that such an unusually high rate, compared to other countries, could be related to three factors: (a) the higher mean age distribution of the Italian population, (b) the frequent presence of comorbidities in the Italian elderly and (c) the uneven criteria used by the different regional authorities to select candidates for the SARS-CoV-2 RT-PCR tests. According to official data (origin: Italian National Institute of Health, March 26th 2020) the case-fatality rate related to the virus would have reached 9.2% in Italy, with 73,780 infected individuals and 6,801 deaths (4). According to an Oxford Centre for Evidence-Based Medicine estimate, based on www.worldometers.info data, the COVID-19 fatality rate in Italy would have rocketed to 10.09% (5). Considering the variability of data, it would have been more congruous to make comparisons and evaluations using mortality rates rather than case-fatality rates (6,7), because the information on COVID-19 epidemic in Italy has always been so deeply affected by the selection biases, concerning the subjects who were submitted to diagnostic swabs to identify COVID-19 infection, that speaking in terms of case-fatality rates is fully misleading because of the unreliability of the denominators. This because many patients who died at home were not submitted to any test for the disease; sampling on the population and on healthcare professionals, if any, were incomplete etc. But, alas, there are problems also with mortality rates! In an important alert published on 17th April 2020 on its website, the Italian National Institute of Statistic (ISTAT) declared that it will be impossible, by the end of the first four months of 2020, even to compare the January-April 2020 overall mortality of the Italian population with the one of 2019 or 2017-2019, because of a remarkable delay of 2020 data coming from many areas of the nation (8). On the 23rd of march the President of Confindustria (Italian Industrial Entrepreneurs Association), Dr. Vincenzo Boccia, declared that the government restrictions will cause a loss of 100 billions Euros per month to the overall Italian economic activity and that “from business emergency we will get into a economic war context”, stating that imposed restrictions, compelling 70% of economic activities to temporarily shutdown, will have a tremendous social and economic impact (9). According to a study developed by the EngageMinds Hub Research Group (Catholic University of Milan), at least one third of Italian population will suffer from a psycological state defined “alert state”: those subjects who are particularly afraid and confused with COVID-19 emergency, will act in dysfunctional and inappropriate way in relation to the healthcare system (10). But nobody is in the position to make an accurate forecast about the escalation of the “alert state” of people and its psychological consequences. In Italy we have already experienced riots in prisons and also escapes due to the perception of the pandemic emergency (11); perceptions made frightening by the information offered daily by the media, that list the raw numbers of cases and deaths, which can impress beyond any measure if not carefully explained and commented. That way used to inform the lay public only increases the social alert, which can therefore result in generalized fear and panic. On the basis of the number of cases diagnosed, and of the advanced stage of the disease in some Italian patients it is reasonable to believe that the virus had been circulating within the Italian population since January 2020, long before the present government restrictions were enforced. Some scientists are extremely worried about the escalation of psychological alert of the population, claiming that collateral damages from restrictions could induce more deaths than the virus itself: they define the restrictions imposed by the government as incongruous, because often controversial and not properly based on real evidences emerging from reliable studies, and accompanied by a kind of malice by the local authorities in prosecuting the offenders of the restrictions (12,13). Other scientists, such as the mathematician Prof. Isaac Ben Israel, are convinced that the statistical analysis of the data reveal that lockdown measures do not positively affect the curves of spreading of the contagion among the population (14). Some experts underline the lack of specific, robust data regarding efficacy of lockdown measures vs an appropriate use of social distancing and correct hygienic interventions, supporting the need of a more responsible approach to the situation (15). Many papers regarding the negative clinical, behavioural and psycological effects of the pandemic on the whole population has been published, underlying the possible worsening of other pathological conditions that alredy do affect the population: overweight, due to lack of physical exercise vs unmodified diet; increase in drugs, cigarettes and alcohol consumption, less sun exposure, increase of domestic violence, worsening of psychiatric diseases (6,16). Alerts from scientists have already appeared not only on scientific literature, but also on popular newspapers, suggesting to consider all of these potential risks, focusing on the need of correct public health interventions and, consequently, on revisiting the restrictive measures (17). In order to mitigate the economic panic that is progressively affecting people, we should try to re-think preventive measures aiming to protect mainly those groups of subjects that are really at risk of developing severe COVID-19 clinical pictures and that actually are not, or not enough. An interesting proposal could consist in severe quarantine of well-known infected subjects and in classifying the population in 3 categories by age, confining for example, over 70 years and older people to strict, complete seclusion as long as necessary, people between 45 and 70 years old to intermediate protective measures (individual protective devices, social distancing, essential movements) and people younger than 45 to freely participation to common daily life and to carry on economic activities and avoid economic default, considering the lower risk of the latter to develop a severe disease, and so contributing to increase herd immunity. Moreover, the population should be classified by co-morbidities that have been clearly shown as associated to severe COVID-19 clinical pictures, suggesting an ad hoc restrictions within the above mentioned third group. An impressive increase in ICU beds have been rapidly achieved in all Italian regions in an extremely short period of time, and this achievement has significantly helped to cure the worst cases of the disease. But a wise National (and the Regional) Health Services should have prepared themselves in advance to face up to the principal kinds of emergencies, including epidemics and pandemics, as stated by the Italian legislation, from the original L 225/1992 (Istituzione del Servizio Nazionale di Protezione Civile) to the more recent Legislative Decree 1/2018 (Codice della Protezione Civile). On the contrary, according to a report prepared by the GIMBE research group (Evidence-Based Medicine, Italian Research Group) the public investments in the healthcare system were reduced by approximately 37 billion Euros in the last 10 years in Italy, cutting off many hospital beds and reducing the role and the weight of Public Health Departments (18). Now, as a positive contribution to the program of “recovery”, we suggest that data on positivity, disease, and death be collected with more careful attention to their epidemiological use; that restrictions in phase 2 be redesigned, providing the maximum protection for the most fragile sections of the population, but allowing subjects at lesser risk of fatal consequences to be employed for a kind of “production renaissance”, and avoiding the psychological, economic and social damages of unnecessary restrictions. The risk exists that interventions not based on proved evidence could add more victims to the irrecoverable fatalities dues to the COVID-19 pandemic.
  7 in total

1.  What Other Countries Can Learn From Italy During the COVID-19 Pandemic.

Authors:  Stefania Boccia; Walter Ricciardi; John P A Ioannidis
Journal:  JAMA Intern Med       Date:  2020-07-01       Impact factor: 21.873

2.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.

Authors:  Graziano Onder; Giovanni Rezza; Silvio Brusaferro
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

3.  COVID-19 pandemic and addiction: Current problems and future concerns.

Authors:  Sujita Kumar Kar; S M Yasir Arafat; Pawan Sharma; Ayushi Dixit; Marthoenis Marthoenis; Russell Kabir
Journal:  Asian J Psychiatr       Date:  2020-04-10

4.  The differential psychological distress of populations affected by the COVID-19 pandemic.

Authors:  Jie Zhang; Huipeng Lu; Haiping Zeng; Shining Zhang; Qifeng Du; Tingyun Jiang; Baoguo Du
Journal:  Brain Behav Immun       Date:  2020-04-15       Impact factor: 7.217

5.  COVID-19 in Italy: impact of containment measures and prevalence estimates of infection in the general population.

Authors:  Carlo Signorelli; Thea Scognamiglio; Anna Odone
Journal:  Acta Biomed       Date:  2020-04-10

6.  10 Questions and 4 experts on Corona: Answers by Akiko Iwasaki, Gérard Krause, Samuel Alizon, and Rino Rappuoli.

Authors:  Celine K Carret
Journal:  EMBO Mol Med       Date:  2020-04-24       Impact factor: 12.137

7.  Real estimates of mortality following COVID-19 infection.

Authors:  David Baud; Xiaolong Qi; Karin Nielsen-Saines; Didier Musso; Léo Pomar; Guillaume Favre
Journal:  Lancet Infect Dis       Date:  2020-03-12       Impact factor: 25.071

  7 in total
  11 in total

1.  Lockdown During COVID-19: The Greek Success.

Authors:  Dimitrios Moris; Dimitrios Schizas
Journal:  In Vivo       Date:  2020-06       Impact factor: 2.155

Review 2.  Can Air-Conditioning Systems Contribute to the Spread of SARS/MERS/COVID-19 Infection? Insights from a Rapid Review of the Literature.

Authors:  Francesco Chirico; Angelo Sacco; Nicola Luigi Bragazzi; Nicola Magnavita
Journal:  Int J Environ Res Public Health       Date:  2020-08-20       Impact factor: 3.390

Review 3.  COVID-19: Current knowledge in clinical features, immunological responses, and vaccine development.

Authors:  Ramandeep Singh; Alisha Kang; Xiangqian Luo; Mangalakumari Jeyanathan; Amy Gillgrass; Sam Afkhami; Zhou Xing
Journal:  FASEB J       Date:  2021-03       Impact factor: 5.834

4.  The Aftermath of COVID-19 Lockdown on Daily Life Activities in Orthopaedic Patients.

Authors:  Pietro Persiani; Daniele De Meo; Elettra Giannini; Valeria Calogero; Tommaso Speziale Varsamis; Armando Ugo Cavallo; Lorena Martini; Gianluca Cera; Flaminia Coluzzi; Ciro Villani
Journal:  J Pain Res       Date:  2021-03-02       Impact factor: 3.133

5.  Health, psychosocial, and economic impacts of the COVID-19 pandemic on people with chronic conditions in India: a mixed methods study.

Authors:  Kavita Singh; Dimple Kondal; Sailesh Mohan; Suganthi Jaganathan; Mohan Deepa; Nikhil Srinivasapura Venkateshmurthy; Prashant Jarhyan; Ranjit Mohan Anjana; K M Venkat Narayan; Viswanathan Mohan; Nikhil Tandon; Mohammed K Ali; Dorairaj Prabhakaran; Karen Eggleston
Journal:  BMC Public Health       Date:  2021-04-08       Impact factor: 3.295

6.  Medically assisted procreation in times of COVID-19: what impact on health care system organization and the reproductive rights of couples?

Authors:  Giuseppe Rallo; Francesca Negro; Francesca Consalvo; Valeria Piersanti; Susanna Marinelli
Journal:  Acta Biomed       Date:  2021-11-03

7.  Booster Vaccination Strategies for "Living With COVID-19".

Authors:  Jung Eun Kim; Sunmi Lee; Hee-Sung Kim
Journal:  Front Public Health       Date:  2022-06-03

8.  The rebirth of health system in Italy after COVID-19 pandemia: starting points.

Authors:  Alessandro Guido Actis; Gianpiero Actis
Journal:  Acta Biomed       Date:  2020-04-28

9.  Early public research funding response to COVID-19 pandemic in Brazil.

Authors:  Kaio Niitsu Campo; Isabella Caroline Pereira Rodrigues; Éder Sócrates Najar Lopes; Laís Pellizzer Gabriel
Journal:  Rev Soc Bras Med Trop       Date:  2020-09-21       Impact factor: 1.581

10.  Mental health crisis in healthcare providers in the COVID-19 pandemic: a cross-sectional facility-based survey.

Authors:  Chih-Wei Sung; Chi-Hsin Chen; Cheng-Yi Fan; Jia-How Chang; Chia Chun Hung; Chia-Ming Fu; Li Ping Wong; Edward Pei-Chuan Huang; Tony Szu-Hsien Lee
Journal:  BMJ Open       Date:  2021-07-28       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.